• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

High BMI Associated With Increased Risk of Type 1 Diabetes

News
Article

In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes.

This article was originally published by Contemporary Pediatrics®.

The role of obesity in the development of type 1 diabetes (T1D) is uncertain. According to a systematic review and meta-analysis recently published in Cardiovascular Diabetology, an association between high body mass index (BMI) and the risk of T1D was observed, in a graded manner.

Peak incidence of T1D occurs in the age range of 10 to 14 years, while 25% of individuals with T1D develop it during adulthood. Because of misclassification of diabetes type and the absence of distinction between risk factors, such as birth weight, and diabetes type, uncertainty exists regarding the relationship between obesity and T1D.

Type 1 diabetes | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Type 1 diabetes | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Study authors conducted a systematic review of 10 cohort studies to synthesize evidence for the T1D incidence-obesity relationship. The investigators searched published literature using the Ovid MEDLINE and EMBASE databases. “Type 1,” “early onset,” “juvenile,” and “insulin dependent” were used to identify T1D.

The cohort studies were included in the systematic review if: exposure was obesity, overweight, or both, measured by BMI at a given time-point, the studies featured BMI data after 2 years of age, and studies followed patients for the development of T1D.

After searches, exclusions, and review, 10 cohort studies met inclusion criteria. Of these, 7 studies evaluated BMI as a categorical variable while the remaining 3 used continuous BMI data. In the 7 studies with categorical BMI data, the mean or median age at study ranged between 2 years and 59 years.

Among these studies, 4 cohort studies featured just children and adolescents aged younger than 20 years, while the other 3 included adults (aged 20 years or older) only. Overall, data provide information on 1,690,660 individuals and 1979 cases of incident T1D (0.12%).

The risk ratio (RR) for T1D among individuals with obesity or overweight and obesity was 1.87 (1.52-2.29), compared with individuals without overweight or obesity. Among those with overweight or obesity, all studies reported a trend of higher risk for T1D.

Five studies separated overweight and obesity categories. In these cohorts, the pooled RR for incident T1D in individuals with obesity was 2.17 (95% CI, 1.75-2.69 [I2 = 0%]). Three studies that featured people with overweight had a pooled RR of 1.35 (95% CI, 0.93-1.97).

Overall, study authors concluded that high BMI was associated with an increased risk of incident T1D and that, “these results provide real-world evidence for the deleterious contribution of obesity to the development of type 1 diabetes.”

Reference

Nitecki M, Gerstein HC, Balmakov Y, et al. High BMI and the risk for incident type 1 Diabetes Mellitus: a systematic review and meta-analysis of aggregated cohort studies. Cardiovasc Diabetol. 2023;22(1):300. doi:10.1186/s12933-023-02007-y

Related Videos
Video 7 - "Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words"
Video 6 - "Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus"
Video 5 - "Strategies for Preventing Progression of Early-Stage Type 1 Diabetes"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Video 3 - "Identifying Risk to Enable Early Detection of Type 1 Diabetes "
Video 2 - "Early-stage Type 1 Diabetes and The Psychological Impact of Progressing to Stage 3"
Camilla Levister, MS, ANP-C
Video 1 - "Unraveling Type 1 Diabetes: Differences Between Type 1 and Type 2"
Camilla Levister
Camilla Levister
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.